AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (July 24, 2003). doi:10.1152/ajpheart.00187.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/H2420    most recent
00187.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, G.
Right arrow Articles by Li, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, G.
Right arrow Articles by Li, J.
Submitted on February 28, 2003
Accepted on July 21, 2003

Hypoxia Induces Myocyte-dependent COX-2 Regulation in Endothelial Cells -Role of VEGF

Guifu Wu1, Arjuna P. Mannam1, Jiaping Wu1, Simona Kirbis1, Jue-Lon Shie1, Christopher Chen2, Roger J. Laham1, Frank W. Sellke3, and Jian Li1*

1 Department of Cardiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA
2 Department of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA
3 Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA

* To whom correspondence should be addressed. E-mail: jli{at}BIDMC.harvard.edu.

There is increasing evidence that Cyclooxygenase-2 (COX-2) possess both angiogenic and cardioprotective properties. We examined the effects of hypoxic-cardiac myocytes (H9c2) on COX-2 expression in human umbilical vein endothelial cells (HUVECs) to determine the pathway involved in COX-2 regulation. The medium from hypoxic (<1% O2) cardiac myocytes (HMCM) or normoxic cardiac myocytes (21% O2) was added to HUVEC cultures. The HMCM induced a transient increase of COX-2 mRNA expression at 1 and 3 hours, without affecting COX-1 mRNA level. A similar effect also observed in HMCM from cultured primary cardiac myocytes (Rat neonatal cardiac myocytes, RNCM). The increased COX-2 mRNA was associated with a time-dependent increase in COX-2 protein expression. COX-2 was significantly induced by VEGF (4.86±1.03 fold) and IL-1{beta} (3.93±0.89 fold), slightly increased by TNF-{alpha}, but not by FGF2, IGF-1 or PDGFs. Analysis of proteins secreted in HMCM showed the increased levels of VEGF but not IL-1{beta} or TNF-{alpha}. The HMCM induced COX-2 expression was inhibited by the addition of an anti-VEGF neutralizing antibody. VEGF induced endothelial cell COX-2 expression by both increasing COX-2 transcription and by prolonging COX-2 mRNA half-life. Furthermore, staurosporine, a non-selective PKC inhibitor, prevented the induction of VEGF by hypoxia. Both selective PKC {alpha}, {beta}1 inhibitor and iNOS inhibitor decreased the induction of COX-2 by HMCM and VEGF. Finally, HMCM-induced upregulation of COX-2 was accompanied by upregulation of PGI2 and PGE2. These results suggest that VEGF is one of the principal factors produced by the hypoxic myocytes that is responsible for the induction of endothelial cell COX-2 expression. This process likely involves both PKC and NOS pathways. Our findings have important implications regarding the cardiac protection of COX-2 in ischemic heart disease




This article has been cited by other articles:


Home page
CirculationHome page
X. An, Y. Jin, H. Guo, S.-Y. Foo, B. L. Cully, J. Wu, H. Zeng, A. Rosenzweig, and J. Li
Response Gene to Complement 32, a Novel Hypoxia-Regulated Angiogenic Inhibitor
Circulation, August 18, 2009; 120(7): 617 - 627.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Sahin, E. Sahin, and S. Gumuslu
Cyclooxygenase-2 in Cancer and Angiogenesis
Angiology, April 1, 2009; 60(2): 242 - 253.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Voisine, A. Rosinberg, J. J. Wykrzykowska, Y. Shamis, G. F. Wu, E. Appelbaum, J. Li, F. W. Sellke, D. Pinto, C. M. Gibson, et al.
Skin-derived microorgan autotransplantation as a novel approach for therapeutic angiogenesis
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H213 - H219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Geng, Y. Cui, J. Zhao, F. Yu, Y. Zhu, G. Xu, Z. Zhang, C. Tang, and J. Du
Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1608 - R1618.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. S. Boosani, A. P. Mannam, D. Cosgrove, R. Silva, K. M. Hodivala-Dilke, V. G. Keshamouni, and A. Sudhakar
Regulation of COX-2 mediated signaling by {alpha}3 type IV noncollagenous domain in tumor angiogenesis
Blood, August 15, 2007; 110(4): 1168 - 1177.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Rydkina, A. Sahni, R. B. Baggs, D. J. Silverman, and S. K. Sahni
Infection of Human Endothelial Cells with Spotted Fever Group Rickettsiae Stimulates Cyclooxygenase 2 Expression and Release of Vasoactive Prostaglandins
Infect. Immun., September 1, 2006; 74(9): 5067 - 5074.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Wu, J. Luo, J. S. Rana, R. Laham, F. W. Sellke, and J. Li
Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells
Cardiovasc Res, February 1, 2006; 69(2): 512 - 519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. M. Kuldo, J. Westra, S. A. Asgeirsdottir, R. J. Kok, K. Oosterhuis, M. G. Rots, J. P. Schouten, P. C. Limburg, and G. Molema
Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1229 - C1239.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ferrario, A. M. Fisher, N. Rucker, and C. J. Gomer
Celecoxib and NS-398 Enhance Photodynamic Therapy by Increasing In vitro Apoptosis and Decreasing In vivo Inflammatory and Angiogenic Factors
Cancer Res., October 15, 2005; 65(20): 9473 - 9478.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. C. Sasso, D. Torella, O. Carbonara, G. M. Ellison, M. Torella, M. Scardone, C. Marra, R. Nasti, R. Marfella, D. Cozzolino, et al.
Increased Vascular Endothelial Growth Factor Expression But Impaired Vascular Endothelial Growth Factor Receptor Signaling in the Myocardium of Type 2 Diabetic Patients With Chronic Coronary Heart Disease
J. Am. Coll. Cardiol., September 6, 2005; 46(5): 827 - 834.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. N. Christensen, M. Kochukov, T. A. McNearney, G. Taglialatela, and K. N. Westlund
Proton-sensing G protein-coupled receptor mobilizes calcium in human synovial cells
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C601 - C608.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
L. P. Thompson, K. Aguan, and H. Zhou
Chronic Hypoxia Inhibits Contraction of Fetal Arteries by Increased Endothelium-Derived Nitric Oxide and Prostaglandin Synthesis
Reproductive Sciences, December 1, 2004; 11(8): 511 - 520.
[Abstract] [PDF]


Home page
Cancer Res.Home page
J. Chung, S. Yoon, K. Datta, R. E. Bachelder, and A. M. Mercurio
Hypoxia-Induced Vascular Endothelial Growth Factor Transcription and Protection from Apoptosis Are Dependent on {alpha}6{beta}1 Integrin in Breast Carcinoma Cells
Cancer Res., July 15, 2004; 64(14): 4711 - 4716.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.